Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Articles online first > Giornale Italiano di Dermatologia e Venereologia 2016 Jun 10

CURRENT ISSUEGIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014


eTOC

 

Giornale Italiano di Dermatologia e Venereologia 2016 Jun 10

language: English

Interleukine levels and macrophagic density in periumbilical fat tissue in patients affected by moderate to severe psoriasis with metabolic syndrome, before and after Etanercept treatment

Alberico Motolese 1, Valeria Chiaravalloti 1, Michele Cerati 2, Rita Oldrini 2, Federica Mola 1, Alberto Passi 3

1 Department of Dermatology, Macchi Hospital, Varese, Italy; 2 Department of Histopathology, Macchi Hospital, Varese, Italy;3 Department of Experimental and Clinical Biomedical Sciences, University of Insubria, Varese, Italy


PDF  REPRINTS


Psoriasis is a chronic inflammatory and immunological mediated skin disease characterized by epidermic proliferation, keratinocytes diversification disorder, excessive angiogenesis and immunological dysfunctions. Lately, the association of psoriasis with several comorbidities increased. Cardiovascular and metabolic disorders can be related to inflammatory conditions in which pro-inflammatory cytokines secreted by adipose tissue such as TNF-alpha increase. The aim of our study was to investigate the relation between abdominal adipose tissue inflammatory state and metabolic syndrome in 10 patients affected by moderate to severe psoriasis. Umbilical fat tissue biopsies were carried out before and after 24 weeks of treatment with TNF-alpha inhibitor (etanercept). Morphological parameters of macrophages were estimated using immunohistochemistry methods and Hematoxilyn – Eosin (H&E) coloration; IL-6 and TNF-alpha and IL1B were measured using molecular biology techniques. After 24 weeks of treatment with TNF-alpha inhibitor (etanercept), a decrease of macrophages infiltration, inflammatory citokyne levels and gene expression were noticed.

top of page